256 related articles for article (PubMed ID: 20130046)
1. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.
Huch JH; Cunningham AL; Arvin AM; Nasr N; Santegoets SJ; Slobedman E; Slobedman B; Abendroth A
J Virol; 2010 Apr; 84(8):4060-72. PubMed ID: 20130046
[TBL] [Abstract][Full Text] [Related]
2. Varicella zoster virus immune evasion strategies.
Abendroth A; Kinchington PR; Slobedman B
Curr Top Microbiol Immunol; 2010; 342():155-71. PubMed ID: 20563710
[TBL] [Abstract][Full Text] [Related]
3. Expression of C-type lectin receptors by subsets of dendritic cells in human skin.
Ebner S; Ehammer Z; Holzmann S; Schwingshackl P; Forstner M; Stoitzner P; Huemer GM; Fritsch P; Romani N
Int Immunol; 2004 Jun; 16(6):877-87. PubMed ID: 15113774
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.
Ku CC; Zerboni L; Ito H; Graham BS; Wallace M; Arvin AM
J Exp Med; 2004 Oct; 200(7):917-25. PubMed ID: 15452178
[TBL] [Abstract][Full Text] [Related]
5. Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin AM
J Virol; 2000 Feb; 74(4):1900-7. PubMed ID: 10644363
[TBL] [Abstract][Full Text] [Related]
6. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
Choi EJ; Lee CH; Shin OS
Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use.
Nikkels AF; Debrus S; Sadzot-Delvaux C; Piette J; Rentier B; Piérard GE
J Med Virol; 1995 Dec; 47(4):342-7. PubMed ID: 8636701
[TBL] [Abstract][Full Text] [Related]
9. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
[TBL] [Abstract][Full Text] [Related]
10. Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.
Gutzeit C; Raftery MJ; Peiser M; Tischer KB; Ulrich M; Eberhardt M; Stockfleth E; Giese T; Sauerbrei A; Morita CT; Schönrich G
J Immunol; 2010 Jul; 185(1):488-97. PubMed ID: 20525895
[TBL] [Abstract][Full Text] [Related]
11. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
[TBL] [Abstract][Full Text] [Related]
12. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
[TBL] [Abstract][Full Text] [Related]
13. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM
J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.
Morrow G; Slobedman B; Cunningham AL; Abendroth A
J Virol; 2003 Apr; 77(8):4950-9. PubMed ID: 12663800
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
Front Immunol; 2020; 11():1. PubMed ID: 32038653
[TBL] [Abstract][Full Text] [Related]
16. Varicella Zoster Virus infects mucosal associated Invariant T cells.
Purohit SK; Corbett AJ; Slobedman B; Abendroth A
Front Immunol; 2023; 14():1121714. PubMed ID: 37006246
[TBL] [Abstract][Full Text] [Related]
17. Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.
Sen N; Sung P; Panda A; Arvin AM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089701
[TBL] [Abstract][Full Text] [Related]
18. Construction of a pathological model of skin lesions in acute herpes zoster virus infection and its molecular mechanism.
Zhou H; Ye Z; Gao Z; Xi C; Yin J; Sun Y; Sun B
Mamm Genome; 2024 Jun; 35(2):296-307. PubMed ID: 38600211
[TBL] [Abstract][Full Text] [Related]
19. IFN-α production by human mononuclear cells infected with varicella-zoster virus through TLR9-dependent and -independent pathways.
Yu HR; Huang HC; Kuo HC; Sheen JM; Ou CY; Hsu TY; Yang KD
Cell Mol Immunol; 2011 Mar; 8(2):181-8. PubMed ID: 21317915
[TBL] [Abstract][Full Text] [Related]
20. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
